Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.

Conner SC, Benayoun L, Himali JJ, Adams SL, Yang Q, DeCarli C, Blusztajn JK, Beiser A, Seshadri S, Delalle I.

J Alzheimers Dis. 2019 Feb 11. doi: 10.3233/JAD-180977. [Epub ahead of print]

PMID:
30775993
2.

Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

Adams SL, Benayoun L, Tilton K, Mellott TJ, Seshadri S, Blusztajn JK, Delalle I.

J Alzheimers Dis. 2018;63(4):1433-1443. doi: 10.3233/JAD-171065.

3.

Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.

Adams SL, Benayoun L, Tilton K, Chavez OR, Himali JJ, Blusztajn JK, Seshadri S, Delalle I.

J Alzheimers Dis. 2017;60(1):43-56. doi: 10.3233/JAD-170459.

4.

Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia.

Agís-Balboa RC, Pinheiro PS, Rebola N, Kerimoglu C, Benito E, Gertig M, Bahari-Javan S, Jain G, Burkhardt S, Delalle I, Jatzko A, Dettenhofer M, Zunszain PA, Schmitt A, Falkai P, Pape JC, Binder EB, Mulle C, Fischer A, Sananbenesi F.

EMBO J. 2017 Oct 2;36(19):2815-2828. doi: 10.15252/embj.201796821. Epub 2017 Aug 2.

5.

HDAC1 links early life stress to schizophrenia-like phenotypes.

Bahari-Javan S, Varbanov H, Halder R, Benito E, Kaurani L, Burkhardt S, Anderson-Schmidt H, Anghelescu I, Budde M, Stilling RM, Costa J, Medina J, Dietrich DE, Figge C, Folkerts H, Gade K, Heilbronner U, Koller M, Konrad C, Nussbeck SY, Scherk H, Spitzer C, Stierl S, Stöckel J, Thiel A, von Hagen M, Zimmermann J, Zitzelsberger A, Schulz S, Schmitt A, Delalle I, Falkai P, Schulze TG, Dityatev A, Sananbenesi F, Fischer A.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4686-E4694. doi: 10.1073/pnas.1613842114. Epub 2017 May 22. Erratum in: Proc Natl Acad Sci U S A. 2017 Jul 10;:.

6.

miR-149 and miR-29c as candidates for bipolar disorder biomarkers.

Choi JL, Kao PF, Itriago E, Zhan Y, Kozubek JA, Hoss AG, Banigan MG, Vanderburg CR, Rezvani AH, Latourelle JC, Cabral H, Delalle I.

Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):315-323. doi: 10.1002/ajmg.b.32518. Epub 2017 Feb 12.

PMID:
28190298
7.

Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.

Ramkissoon SH, Bandopadhayay P, Hwang J, Ramkissoon LA, Greenwald NF, Schumacher SE, O'Rourke R, Pinches N, Ho P, Malkin H, Sinai C, Filbin M, Plant A, Bi WL, Chang MS, Yang E, Wright KD, Manley PE, Ducar M, Alexandrescu S, Lidov H, Delalle I, Goumnerova LC, Church AJ, Janeway KA, Harris MH, MacConaill LE, Folkerth RD, Lindeman NI, Stiles CD, Kieran MW, Ligon AH, Santagata S, Dubuc AM, Chi SN, Beroukhim R, Ligon KL.

Neuro Oncol. 2017 Jul 1;19(7):986-996. doi: 10.1093/neuonc/now294.

8.

Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.

Adams SL, Tilton K, Kozubek JA, Seshadri S, Delalle I.

J Neuropathol Exp Neurol. 2016 Aug;75(8):779-790. Epub 2016 Jun 26.

9.

Monoaminergic neuropathology in Alzheimer's disease.

Šimić G, Babić Leko M, Wray S, Harrington CR, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik CM, Hof PR.

Prog Neurobiol. 2017 Apr;151:101-138. doi: 10.1016/j.pneurobio.2016.04.001. Epub 2016 Apr 12. Review.

10.

Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.

Olmos-Serrano JL, Kang HJ, Tyler WA, Silbereis JC, Cheng F, Zhu Y, Pletikos M, Jankovic-Rapan L, Cramer NP, Galdzicki Z, Goodliffe J, Peters A, Sethares C, Delalle I, Golden JA, Haydar TF, Sestan N.

Neuron. 2016 Mar 16;89(6):1208-1222. doi: 10.1016/j.neuron.2016.01.042. Epub 2016 Feb 25.

11.

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.

Šimić G, Babić Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik C, Hof PR.

Biomolecules. 2016 Jan 6;6(1):6. doi: 10.3390/biom6010006. Review.

12.

Activity-dependent p25 generation regulates synaptic plasticity and Aβ-induced cognitive impairment.

Seo J, Giusti-Rodríguez P, Zhou Y, Rudenko A, Cho S, Ota KT, Park C, Patzke H, Madabhushi R, Pan L, Mungenast AE, Guan JS, Delalle I, Tsai LH.

Cell. 2014 Apr 10;157(2):486-498. doi: 10.1016/j.cell.2014.01.065.

13.

An enigmatic brainstem posterior fossa ganglioglioma in an adult.

Qin B, Tabbara AK, Delalle I, Holsapple J, Hohler A.

Int J Neurosci. 2014 Sep;124(9):704-6. doi: 10.3109/00207454.2013.877901. Epub 2014 Jan 29.

PMID:
24405263
14.

Bilirubin labeling of borderzone and anterior cerebral artery territory infarction.

Berkowitz AL, Sheu SH, Rose MF, Delalle I, Folkerth RD.

Neurology. 2013 Oct 1;81(14):1272-3. doi: 10.1212/WNL.0b013e3182a6cbb2. No abstract available.

15.

Insulin growth factor binding protein 7 is a novel target to treat dementia.

Agbemenyah HY, Agis-Balboa RC, Burkhardt S, Delalle I, Fischer A.

Neurobiol Dis. 2014 Feb;62:135-43. doi: 10.1016/j.nbd.2013.09.011. Epub 2013 Sep 25.

PMID:
24075854
16.

Intractable hiccups resolved after resection of a cavernous malformation of the medulla oblongata.

Thaci B, Burns JD, Delalle I, Vu T, Davies KG.

Clin Neurol Neurosurg. 2013 Oct;115(10):2247-50. doi: 10.1016/j.clineuro.2013.07.005. Epub 2013 Aug 7. No abstract available.

PMID:
23932467
17.

Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients.

Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J, Schmitt A, Schneider A, Cabral H, Cagsal-Getkin O, Vanderburg CR, Delalle I.

PLoS One. 2013;8(1):e48814. doi: 10.1371/journal.pone.0048814. Epub 2013 Jan 30.

18.

Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology.

Kao PF, Banigan MG, Vanderburg CR, McKee AC, Polgar PR, Seshadri S, Delalle I.

J Neuropathol Exp Neurol. 2012 Jul;71(7):654-64. doi: 10.1097/NEN.0b013e31825d06b7.

19.

HDAC1 regulates fear extinction in mice.

Bahari-Javan S, Maddalena A, Kerimoglu C, Wittnam J, Held T, Bähr M, Burkhardt S, Delalle I, Kügler S, Fischer A, Sananbenesi F.

J Neurosci. 2012 Apr 11;32(15):5062-73. doi: 10.1523/JNEUROSCI.0079-12.2012.

20.

An epigenetic blockade of cognitive functions in the neurodegenerating brain.

Gräff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, Su SC, Samiei A, Joseph N, Haggarty SJ, Delalle I, Tsai LH.

Nature. 2012 Feb 29;483(7388):222-6. doi: 10.1038/nature10849.

21.

Diffuse central neurocytoma with craniospinal dissemination.

Stapleton CJ, Walcott BP, Kahle KT, Codd PJ, Nahed BV, Chen L, Robison NJ, Delalle I, Goumnerova LC, Jackson EM.

J Clin Neurosci. 2012 Jan;19(1):163-6. doi: 10.1016/j.jocn.2011.07.016. Epub 2011 Nov 15.

PMID:
22088950
22.

microRNA-34c is a novel target to treat dementias.

Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, Farinelli L, Delalle I, Schmitt A, Falkai P, Bahari-Javan S, Burkhardt S, Sananbenesi F, Fischer A.

EMBO J. 2011 Sep 23;30(20):4299-308. doi: 10.1038/emboj.2011.327.

23.

Primary intramedullary histiocytic sarcoma.

Toshkezi G, Edalat F, O'Hara C, Delalle I, Chin LS.

World Neurosurg. 2010 Oct-Nov;74(4-5):523-7. doi: 10.1016/j.wneu.2010.07.002. Epub 2011 Jan 12.

PMID:
21492606
24.

Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease.

Kao PF, Davis DA, Banigan MG, Vanderburg CR, Seshadri S, Delalle I.

PLoS One. 2010 Oct 13;5(10):e13337. doi: 10.1371/journal.pone.0013337.

25.

Capzb2 PROTEIN EXPRESSION IN THE BRAINS OF PATIENTS DIAGNOSED WITH ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE.

Vanderburg CR, Davis DA, Diamond RE, Kao PF, Delalle I.

Transl Neurosci. 2010 Mar;1(1):55-58. doi: 10.2478/v10134-010-0008-9. Epub 2010 Oct 12.

26.

Capzb2 interacts with beta-tubulin to regulate growth cone morphology and neurite outgrowth.

Davis DA, Wilson MH, Giraud J, Xie Z, Tseng HC, England C, Herscovitz H, Tsai LH, Delalle I.

PLoS Biol. 2009 Oct;7(10):e1000208. doi: 10.1371/journal.pbio.1000208. Epub 2009 Oct 6.

27.

Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity.

Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH, Moy LY, Giusti P, Broodie N, Mazitschek R, Delalle I, Haggarty SJ, Neve RL, Lu Y, Tsai LH.

Neuron. 2008 Dec 10;60(5):803-17. doi: 10.1016/j.neuron.2008.10.015.

28.

Pilocytic astrocytoma of the spinal cord in an adult.

Saad A, Tuli S, Ali EN, Houtchens M, Delalle I, Kesari S.

J Neurooncol. 2008 Jun;88(2):189-91. doi: 10.1007/s11060-008-9547-z. No abstract available.

PMID:
18340405
29.

Ganglioglioma associated with cerebral cortical dysplasia: an unusual case with extensive leptomeningeal involvement.

Saad AG, Jayarao M, Chin LS, Delalle I.

Pediatr Dev Pathol. 2008 Nov-Dec;11(6):474-8. doi: 10.2350/07-10-0360.1. Epub 2008 Feb 25.

PMID:
18338935
30.

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis.

Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH.

EMBO J. 2007 Jul 11;26(13):3169-79. Epub 2007 Jun 21.

31.
32.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-2002. A 52-year-old woman with recurrent unsteadiness, slurred speech, and fatigue.

Alderson LM, Delalle I.

N Engl J Med. 2002 Mar 28;346(13):1009-15. No abstract available. Erratum in: N Engl J Med 2002 Jun 6;346(23):1838.

PMID:
11919311
33.

The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development.

Brouns MR, Matheson SF, Hu KQ, Delalle I, Caviness VS, Silver J, Bronson RT, Settleman J.

Development. 2000 Nov;127(22):4891-903.

34.
35.
36.
37.

Laminar distribution of neuropeptide Y-immunoreactive neurons in human prefrontal cortex during development.

Delalle I, Evers P, Kostović I, Uylings HB.

J Comp Neurol. 1997 Mar 24;379(4):515-22.

PMID:
9067840
38.

Regulation of normal proliferation in the developing cerebrum potential actions of trophic factors.

Caviness VS Jr, Takahashi T, Miyama S, Nowakowski RS, Delalle I.

Exp Neurol. 1996 Feb;137(2):357-66. Review.

PMID:
8635552
39.

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.

Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E.

Nature. 1994 Sep 29;371(6496):419-23.

PMID:
8090221
40.

[Terrorist explosions--medical aspects].

Bilić E, Delalle I.

Lijec Vjesn. 1992 May-Aug;114(5-8):177-9. Review. Croatian.

PMID:
1343055
41.

Zagreb research collection of human brains for developmental neurobiologists and clinical neuroscientists.

Kostovic I, Judas M, Kostovic-Knezevic L, Simic G, Delalle I, Chudy D, Sajin B, Petanjek Z.

Int J Dev Biol. 1991 Sep;35(3):215-30.

42.

Prenatal and perinatal development of the somatostatin-immunoreactive neurons in the human prefrontal cortex.

Kostović I, Stefulj-Fucić A, Mrzljak L, Jukić S, Delalle I.

Neurosci Lett. 1991 Apr 1;124(2):153-6.

PMID:
1676833

Supplemental Content

Loading ...
Support Center